報價延遲最少15分鐘:2026/01/30 17:20 EST
盤後時段
|
||||
|
8.36 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.36
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.35/1.17
|
|
企業價值
306.02M
|
| 資產負債 |
|
每股賬面淨值
0.78
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
56.13M
|
|
每股收益
1.85
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others. |
